C-Reactive Protein a Promising Biomarker of COVID-19 Severity
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2021/09/30
-
Indian UGC (journal)
-
Refrences52
-
Citations12
-
Muntaha Fazal Department of Biomedical Laboratory Sciences, School of Health Sciences, University of Management and Technology, Lahore, Pakistan ORCID (unauthenticated)
Cite
Fazal, Muntaha. “C-Reactive Protein a Promising Biomarker of COVID-19 Severity”. Korean Journal of Clinical Laboratory Science, vol. 53, no. 3, 2021, pp. 201-7, https://doi.org/10.15324/kjcls.2021.53.3.201.
Fazal, M. (2021). C-Reactive Protein a Promising Biomarker of COVID-19 Severity. Korean Journal of Clinical Laboratory Science, 53(3), 201-207. https://doi.org/10.15324/kjcls.2021.53.3.201
Fazal M. C-Reactive Protein a Promising Biomarker of COVID-19 Severity. Korean Journal of Clinical Laboratory Science. 2021;53(3):201-7.
Journal Category
Medicine
Medicine (General)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1016/S0140-6736(20)30566-3 | ||||
| Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring | Seminars in Thrombosis and Hemostasis |
| 50 | 2020 |
| Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae | Seminars in Thrombosis and Hemostasis |
| 35 | 2020 |
The cytokine storm and COVID‐19 | Journal of Medical Virology |
| 864 | 2020 |
| C-reactive protein levels in the early stage of COVID-19 | Médecine et Maladies Infectieuses | 379 | 2020 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Ginseng and ginsenosides on cardiovascular and pulmonary diseases; Pharmacological potentials for the coronavirus (COVID-19) | Journal of Ginseng Research |
| 2024 | |
dCROX and ROX Indices Predict Clinical Outcomes in Patients with COVID-19 Pneumonia Treated with High-Flow Nasal Cannula Oxygen Therapy | Critical Care Research and Practice |
| 2024 | |
| SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients | Infection and Drug Resistance |
| 2024 | |
Association of Coagulopathy and Inflammatory Biomarkers with Severity in SARS-CoV-2-Infected Individuals of the Al-Qunfudhah Region of Saudi Arabia | Healthcare |
| 1 | 2024 |
| Association of triglyceride/high-density lipoprotein cholesterol ratio with severe complications of COVID-19 | Heliyon | 2 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 4
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Glutathione: A Samsonian life-sustaining small molecule that protects against oxidative stress, ageing and damaging inflammation and was published in 2022. The most recent citation comes from a 2024 study titled SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients. This article reached its peak citation in 2022, with 5 citations. It has been cited in 12 different journals, 50% of which are open access. Among related journals, the Infection and Drug Resistance cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.